| 21 |
Tapentadol (LCMS) |
Pharmaceutical Drugs |
Toxicology / Drugs |
| 22 |
Tapentadol in urine (GCMS) |
Pharmaceutical Drugs |
Toxicology / Drugs |
| 23 |
Target cells |
Manual Differentiation |
Hematology |
| 24 |
Tau-Protein in CSF (EIA) |
Alzheimer diagnostics |
Clinical Chemistry |
| 25 |
Taurine |
Amino acids plasma/serum |
Metabolic analysis |
| 26 |
Tauro-Chenodesoxycholic acid (TCDC) |
Bile Acids |
Metabolic analysis |
| 27 |
Tauro-Cholic acid (TC) |
Bile Acids |
Metabolic analysis |
| 28 |
Tauro-Ursodesoxycholic acid (TUDC) |
Bile Acids |
Metabolic analysis |
| 29 |
Taurochenodesoxycholic acid (TCDC) |
Bile Acids |
Metabolic analysis |
| 30 |
Taurocholic acid (TC) |
Bile Acids |
Metabolic analysis |
| 31 |
Taurodesoxycholic acid (GDC) |
Bile Acids |
Metabolic analysis |
| 32 |
Tauroursodesoxycholic acid (TUDC) |
Bile Acids |
Metabolic analysis |
| 33 |
TB1 Tube (ESAT-6, CFP-10) |
Tuberkulosis |
Infectious diseases |
| 34 |
TB2 Tube (ESAT-6, CFP-10, add. Peptide combination) |
Tuberkulosis |
Infectious diseases |
| 35 |
TBC IgA antibody (EIA) |
Tuberkulosis |
Infectious diseases |
| 36 |
TBC IgG antibody (EIA) |
Tuberkulosis |
Infectious diseases |
| 37 |
TBC IgM antibody (EIA) |
Tuberkulosis |
Infectious diseases |
| 38 |
TBC QuantiFERON Gold IT (EIA) |
Tuberkulosis |
Infectious diseases |
| 39 |
TBC QuantiFERON Gold Plus (EIA) |
Tuberkulosis |
Infectious diseases |
| 40 |
TdT (Term. Desoxynucl.Transf.) |
Term. Desoxynucl. Transf. |
CSF |
ar
